Petra Kleiblová

2.5k total citations
47 papers, 1.0k citations indexed

About

Petra Kleiblová is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Petra Kleiblová has authored 47 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 23 papers in Genetics and 15 papers in Oncology. Recurrent topics in Petra Kleiblová's work include BRCA gene mutations in cancer (19 papers), DNA Repair Mechanisms (12 papers) and Genetic factors in colorectal cancer (8 papers). Petra Kleiblová is often cited by papers focused on BRCA gene mutations in cancer (19 papers), DNA Repair Mechanisms (12 papers) and Genetic factors in colorectal cancer (8 papers). Petra Kleiblová collaborates with scholars based in Czechia, Australia and Denmark. Petra Kleiblová's co-authors include Zdeněk Kleibl, Markéta Janatová, Libor Macůrek, Jana Soukupová, Petra Zemánková, Martin Haluzı́k, Petr Pohlreich, Drahomíra Springer, Pavel Dundr and Jan Benada and has published in prestigious journals such as The Journal of Cell Biology, PLoS ONE and Oncogene.

In The Last Decade

Petra Kleiblová

42 papers receiving 983 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Petra Kleiblová Czechia 18 463 323 283 199 175 47 1.0k
Yalan Bi China 16 163 0.4× 221 0.7× 62 0.2× 80 0.4× 85 0.5× 51 718
W. B�cker Germany 20 398 0.9× 321 1.0× 115 0.4× 88 0.4× 111 0.6× 43 1.0k
Darius Dian Germany 19 250 0.5× 187 0.6× 136 0.5× 243 1.2× 137 0.8× 56 1.0k
Christopher Kobierzycki Poland 16 281 0.6× 200 0.6× 40 0.1× 147 0.7× 58 0.3× 58 742
Anita Chudecka-Głaz Poland 17 227 0.5× 232 0.7× 120 0.4× 155 0.8× 32 0.2× 85 863
Alexander M. Tseng United States 15 579 1.3× 125 0.4× 84 0.3× 267 1.3× 40 0.2× 27 946
Agata Filip Poland 17 319 0.7× 160 0.5× 62 0.2× 175 0.9× 90 0.5× 67 751
Xiaoxin Ma China 19 482 1.0× 224 0.7× 60 0.2× 425 2.1× 32 0.2× 47 969
Florence Mishellany France 17 195 0.4× 295 0.9× 33 0.1× 217 1.1× 79 0.5× 37 811

Countries citing papers authored by Petra Kleiblová

Since Specialization
Citations

This map shows the geographic impact of Petra Kleiblová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Kleiblová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Kleiblová more than expected).

Fields of papers citing papers by Petra Kleiblová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra Kleiblová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Kleiblová. The network helps show where Petra Kleiblová may publish in the future.

Co-authorship network of co-authors of Petra Kleiblová

This figure shows the co-authorship network connecting the top 25 collaborators of Petra Kleiblová. A scholar is included among the top collaborators of Petra Kleiblová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra Kleiblová. Petra Kleiblová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Janatová, Markéta, et al.. (2025). Semi-automated RNA Isolation from Tempus Blood RNA Tubes Using the Magcore Plus II Instrument. Folia Biologica. 71(2). 88–94.
2.
Kleiblová, Petra, Petra Zemánková, J. Hojný, et al.. (2024). Parallel DNA/RNA NGS Using an Identical Target Enrichment Panel in the Analysis of Hereditary Cancer Predisposition. Folia Biologica. 70(1). 62–73. 3 indexed citations
3.
Janatová, Markéta, Eva Macháčková, Jana Soukupová, et al.. (2023). Classification of germline variants identified in cancer predisposition genetic testing – consensus of the CZECANCA consortium. Klinicka onkologie. 36(6). 431–439.
4.
Soukupová, Jana, Petra Kleiblová, Markéta Janatová, et al.. (2023). Importance of Germline and Somatic Alterations in Human MRE11, RAD50, and NBN Genes Coding for MRN Complex. International Journal of Molecular Sciences. 24(6). 5612–5612. 9 indexed citations
5.
Soukupová, Jana, Markéta Janatová, Petra Kleiblová, et al.. (2021). Germline mutations in RAD51C and RAD51D and hereditary predisposition to ovarian cancer. Klinicka onkologie. 34(1). 26–32. 3 indexed citations
6.
Stolařová, Lenka, Eva Macháčková, Petra Zemánková, et al.. (2020). Identification of Germline Mutations in Melanoma Patients with Early Onset, Double Primary Tumors, or Family Cancer History by NGS Analysis of 217 Genes. Biomedicines. 8(10). 404–404. 13 indexed citations
7.
Borecká, Marianna, Petra Zemánková, Filip Lhota, et al.. (2016). The c.657del5 variant in the NBN gene predisposes to pancreatic cancer. Gene. 587(2). 169–172. 12 indexed citations
8.
Lhota, Filip, Petra Zemánková, Petra Kleiblová, et al.. (2016). Hereditary truncating mutations of DNA repair and other genes in BRCA1/BRCA2/PALB2‐negatively tested breast cancer patients. Clinical Genetics. 90(4). 324–333. 25 indexed citations
9.
Burdová, Kamila, et al.. (2016). Inhibition of WIP1 phosphatase sensitizes breast cancer cells to genotoxic stress and to MDM2 antagonist nutlin-3. Oncotarget. 7(12). 14458–14475. 59 indexed citations
10.
Borecká, Marianna, Petra Zemánková, Michal Vočka, et al.. (2016). Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic. Cancer Genetics. 209(5). 199–204. 26 indexed citations
11.
Havránek, Ondřej, Petra Kleiblová, J. Hojný, et al.. (2015). Association of Germline CHEK2 Gene Variants with Risk and Prognosis of Non-Hodgkin Lymphoma. PLoS ONE. 10(10). e0140819–e0140819. 36 indexed citations
12.
Janatová, Markéta, Jana Soukupová, Petra Kleiblová, et al.. (2015). Mutation Analysis of the RAD51C and RAD51D Genes in High-Risk Ovarian Cancer Patients and Families from the Czech Republic. PLoS ONE. 10(6). e0127711–e0127711. 15 indexed citations
13.
Janatová, Markéta, Zdeněk Kleibl, Kamila Veselá, et al.. (2013). The PALB2 Gene Is a Strong Candidate for Clinical Testing in BRCA1 - and BRCA2 -Negative Hereditary Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. 22(12). 2323–2332. 42 indexed citations
14.
Kleiblová, Petra, et al.. (2012). Contribution of the β-ureidopropionase (UPB1) gene alterations to the development of fluoropyrimidine-related toxicity. Pharmacological Reports. 64(5). 1234–1242. 17 indexed citations
15.
16.
Kleiblová, Petra, et al.. (2009). Contribution of dihydropyrimidinase gene alterations to the development of serious toxicity in fluoropyrimidine-treated cancer patients. Cancer Chemotherapy and Pharmacology. 65(4). 661–669. 21 indexed citations
17.
Lacinová, Z, M Dolinková, Petra Kleiblová, et al.. (2007). Changes of endocrine function of adipose tissue in anorexia nervosa: comparison of circulating levels versus subcutaneous mRNA expression. Clinical Endocrinology. 67(5). 674–678. 57 indexed citations
18.
Kleibl, Zdeněk, Ondřej Havránek, Jan Novotný, et al.. (2007). Analysis of CHEK2 FHA domain in Czech patients with sporadic breast cancer revealed distinct rare genetic alterations. Breast Cancer Research and Treatment. 112(1). 159–164. 24 indexed citations
19.
Kleiblová, Petra, Drahomíra Springer, & Martin Haluzı́k. (2006). The influence of hormonal changes during menstrual cycle on serum adiponectin concentrations in healthy women. Physiological Research. 55(6). 661–666. 38 indexed citations
20.
Kleibl, Zdeněk, Jan Novotný, Radek Malı́k, et al.. (2005). The CHEK2 c.1100delC germline mutation rarely contributes to breast cancer development in the Czech Republic. Breast Cancer Research and Treatment. 90(2). 165–167. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yalan Bi Breakdown of academic impact, for papers by W. B�cker Breakdown of academic impact, for papers by Darius Dian Breakdown of academic impact, for papers by Christopher Kobierzycki Breakdown of academic impact, for papers by Anita Chudecka-Głaz Breakdown of academic impact, for papers by Alexander M. Tseng Breakdown of academic impact, for papers by Agata Filip Breakdown of academic impact, for papers by Xiaoxin Ma Breakdown of academic impact, for papers by Florence Mishellany
Rankless by CCL
2026